Search Results 651-660 of 18604 for hepatitis

1. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   Documented virology status of hepatitis, as confirmed by screening hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc) ...

2. Liver cancer - Doctors and departments - Mayo Clinic

   ... Hepatitis infectious disease, Acute liver failure. Show more areas of focus ... Liver transplant, Cirrhosis, Portal hypertension, Liver cancer, Alcoholic ...

3. General Internal Medicine - Doctors - Mayo Clinic

   Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually ...

4. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   ... hepatitis B surface antigen \[HBsAg\]). Subjects with resolved infection (ie., subjects who are HBsAg negative but positive for antibodies to hepatitis B ...

5. breast cancer survivors Archives - Mayo Clinic News Network

   ... hepatitis B or hepatitis C infection. Treatment depends on the size and location of the cancer, how well your liver is functioning and your overall health ...

6. Health Review - Florida - Orientation - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

   Hepatitis B. Documentation of a complete vaccine series; And documentation of blood tests (titers) showing immunity to Hepatitis B. Measles. Mumps. Rubella. MMR.

7. Granuloma annulare - Symptoms and causes - Mayo Clinic

   Infections, such as hepatitis; Tuberculin skin tests; Vaccinations; Sun exposure; Minor skin injuries; Medicines. Granuloma annulare is not contagious. Risk ...

8. Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis - Mayo Clinic

   Subjects with presence of hepatitis C antibody but negative hepatitis C virus RNA without treatment (i.e., spontaneous clearance) may be eligible if all other ...

9. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

   * Note: Hepatitis RNA testing is optional and participants with negative hepatitis C antibody test are not required to also undergo hepatitis C RNA testing.

10. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure, Hepatic ...